Cognition Therapeutics enters $75M ATM offering with Jefferies, terminates prior $40M ATM

COGNITION THERAPEUTICS INC

Entered ATM sales agreement with Jefferies LLC for up to $75M of common stock (December 18, 2025).
Jefferies receives 3.0% commission on gross proceeds of any shares sold under the agreement.
Terminated prior ATM sales agreement with Cantor Fitzgerald & B. Riley effective Dec 18; ~$12.5M remained unsold.
Company retains discretion over timing and amount of sales; no minimum offering required.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.